Researchers Await Sale Of VW Stock

WEST BERLIN—Europe’s biggest private science foundation, derived from Volkswagenwerk AG, is counting on a rebound of world financial markets to secure the capital it needs to meet its ambitious goals for the support of research. A planned November 9 sale of the government’s 16 percent share in the auto maker’s stock has been postponed indefinitely, West German Finance Minister Gerhard Stoltenberg announced earlier this month. The value of the stock package is roughly $2

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WEST BERLIN—Europe’s biggest private science foundation, derived from Volkswagenwerk AG, is counting on a rebound of world financial markets to secure the capital it needs to meet its ambitious goals for the support of research. A planned November 9 sale of the government’s 16 percent share in the auto maker’s stock has been postponed indefinitely, West German Finance Minister Gerhard Stoltenberg announced earlier this month. The value of the stock package is roughly $290 million now. Its market value was five times higher before last month’s crash.

The VW Foundation needs a substantial boost in its total worth, which last year stood at $2.15 billion, to achieve its goals, said Werner Remmers, chairman of its board of regents. In its 25-year history it has spent $4.5 billion on almost 16,000 research, projects. The sciences received half of last year’s $225 million distribution, with the humanities being given 41 percent and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Richard Sietmann

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo